All In Biotech

Free tool

FAERS Monitor: Jornay Pm

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209311 or its brand name (Jornay Pm, Methylphenidate Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

7,834

Serious

4,476

57% of reports

Hospitalization

1,746

Death reported

444

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,140
  • headache420
  • off label use385
  • anxiety379
  • fatigue373
  • nausea353
  • toxicity to various agents335
  • insomnia321
  • product substitution issue293
  • somnolence289
  • drug abuse285
  • disturbance in attention259
  • decreased appetite255
  • suicidal ideation241
  • agitation235

Reports by year received

View as table
YearReports
20042
20051
20061
20073
20088
200918
201014
201118
201269
2013117
2014121
2015440
2016343
2017495
2018576
2019464
2020364
2021413
2022629
2023832
2024950
20251,019
2026937

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,325 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product substitution issueSignal29313.712.33,437
disturbance in attentionSignal25912.911.52,838
drug abuseSignal2859.28.22,082
agitationSignal2358.67.61,575
suicidal ideationSignal2417.16.31,255
toxicity to various agentsSignal3355.34.81,185
somnolenceSignal2893.93.4614
anxietySignal3793.63.2710
insomniaSignal3213.22.9500
decreased appetiteSignal2552.92.6330
drug ineffectiveSignal1,1402.32.2915
headache4201.81.6153
fatigue3731.31.224
nausea3531.21.112
off label use3851.21.111

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.